BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4399358)

  • 1. [Clinical evaluation of adrenergic beta blocking agents in angina pectoris in a double blind trial].
    Saad EA; Prazeres PR; Siqueira PL; Amarante A; Levy S; Benchimol AB
    Arq Bras Cardiol; 1971 Feb; 24(1):7-16. PubMed ID: 4399358
    [No Abstract]   [Full Text] [Related]  

  • 2. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-blocking agents in angina pectoris. A double-blind trial].
    Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
    [No Abstract]   [Full Text] [Related]  

  • 4. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
    Aellig WH; Prichard BN; Richardson GA
    Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta adrenergic receptor blockaders in treatment of angina pectoris. A critical evaluation].
    Lukasik S; Wrabec K; StaƄkowska K; Janicka K
    Pol Tyg Lek; 1973 Jan; 28(1):17-20. PubMed ID: 4405580
    [No Abstract]   [Full Text] [Related]  

  • 7. -Receptor antagonists in angina pectoris.
    Prichard BN
    Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: A comparative study of perhexiline, beta-adrenergic blocking agents and placebos in the management of angina pectoris.
    Armstrong ML
    Postgrad Med J; 1973 Apr; 49():Suppl 3:108-12. PubMed ID: 4587026
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
    Erikssen J; Rod T
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):721-5. PubMed ID: 4397025
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of adrenergic beta-blocking drugs in angina pectoris.
    Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
    Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials with beta-adrenergic blocking agents in angina pectoris.
    J Assoc Physicians India; 1978 Mar; 26(3):193-4. PubMed ID: 32166
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study with a pure adrenergic beta receptors blocker in severe angina pectoris].
    Escudero J; Granados C
    Arch Inst Cardiol Mex; 1972; 42(4):572-9. PubMed ID: 4403727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
    Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
    Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
    [No Abstract]   [Full Text] [Related]  

  • 15. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 16. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 18. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
    Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
    [No Abstract]   [Full Text] [Related]  

  • 19. Practolol--a cardioselective beta adrenergic blocking agents in the treatment of angina pectoris 'a double blind trial'.
    Bhatia ML; Manjuran RJ; Wasir HS; Roy SB
    J Assoc Physicians India; 1975 Jun; 23(6):357-66. PubMed ID: 1102521
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.